OBJECTIVE -Age, BMI, and race/ethnicity are used in National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and American Diabetes Association (ADA) guidelines to prompt screening for pre-diabetes and diabetes, but cutoffs have not been evaluated rigorously.
B
ecause development of type 2 diabetes is preceded by pre-diabetes, a state in which progression to diabetes can be prevented or delayed (1) , the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and the American Diabetes Association (ADA) recommend screening for pre-diabetes if individuals have risk factors of age Ͼ45 years and BMI Ͼ25 kg/m 2 and consideration for age Ͻ45 years if BMI is Ͼ25 kg/m 2 and another risk factor is present (2) . However, screening is infrequent; in one survey, only 70% of patients had any glucose measurement over 3 years and 95% of the measurements taken were random plasma glucose (RPG) (3) . Since there has been little critical examination of the conventional risk factors (age Ͼ45 years, etc.), we compared them with continuous-variable models and with RPG, an alternative screen that is convenient, inexpensive, and commonly performed. As continuous variables, age and BMI contributed independently to risk of diabetes, diabetes or IGT, and dysglycemia (Table 1 , model A, all P Ͻ 0.001), while the trend for black race was nonsignificant except for diabetes or IGT. However, subjects of black race were significantly more likely to have a family history of diabetes (56 vs. 40%) or to be female (69 vs. 57%), both P Ͻ 0.001. In models containing age, BMI, race, sex, and family history along with RPG (Table 1 , model B), the contributions of age, BMI, and race were all significant, but RPG also contributed independently, and the impact of 10 mg/dl higher RPG was greater than that of 5 additional years of age or 5 kg/m 2 more of BMI.
RESEARCH DESIGN AND METHODS
The usefulness of different screening strategies was evaluated by ROC analysis. AROCs for RPG alone as a screen for diabetes (0.81) and dysglycemia (0.72) were highly significant (P Ͻ 0.001) and significantly higher than both the age Ͼ45 years ϩ BMI Ͼ25 kg/m 2 cutoffs (both 0.63) and the age ϩ BMI ϩ black race cutoffs (0.63 and 0.58), P Ͻ 0.001. Compared with screening with the continuous-variable model containing age ϩ BMI ϩ race ϩ sex ϩ family history, screening with RPG was slightly better for diabetes (0.81 vs. 0.78) and comparable for dysglycemia (both 0.72), all P ϭ NS. AROCs for detection of diabetes and dysglycemia by RPG were comparable in subpopulations grouped by age, BMI, family history, etc., and at different times after meals; detection of diabetes was also unaffected by time of day, but detection of dysglycemia was less effective late in the day (not shown).
As an "index of concern," an RPG cutoff level of 125 mg/dl is likely to be costeffective because of high specificity (6) . It provided 93% specificity, 41% sensitivity, and a positive predictive value of 23% for identification of diabetes and 94% specificity, 23% sensitivity, and a positive predictive value of 51% for dysglycemia; such a level could be used to prompt further evaluation.
CONCLUSIONS -Glucose intolerance is more likely in individuals who are older, heavier, and have minority race/ ethnicity, and such factors are often included in models to identify prevalent diabetes. AROCs ranged from 0.58 -0.80 with risk factor models in previous studies (7) (8) (9) (10) (11) , comparable with or lower than RPG alone in the present study. However, we find that combination of risk factors and RPG improves AROC significantly (not shown).
The strengths of our study include large sample size, sex and race balance, range of age and BMI, and a true screening paradigm-measuring RPG at a visit separate from the OGTT. Limitations include subject self-selection, although RPG AROCs were comparable in those with and those without a family history of diabetes (not shown). Further studies will be required to confirm our findings in unselected populations and in other racial/ ethnic groups.
Age, BMI, and race/ethnicity can be used to identify risk of diabetes and dysglycemia, but the screening performance of recommended cutoffs is weak and lower than that of continuousvariable models. However, such models might be cumbersome to use, and their Data are odds ratios and probabilities, n ϭ 1139 for each analysis. (ADA/NIDDK have recommended that screening be performed on individuals who have age Ͼ45 years and are overweight ͓BMI Ͼ25 kg/m 2 ͔ and be considered on the basis of age Ͼ45 years or age Ͻ45 years if BMI is Ͼ25 kg/m 2 and at least one other risk factor is present ͓family history of diabetes, gestational diabetes, or having had a baby weighing Ͼ9 lb, non-Caucasian, dyslipidemia, or hypertension͔ ͓2͔). IFG, impaired fasting glucose 110 -125 mg/dl. performance is no better than RPG alone. Widespread screening via use of RPG levels could aid detection of unrecognized glucose intolerance, as needed to permit early initiation of preventive management.
